Stryker misses quarterly estimates on muted demand for medical devices
· CNA · JoinRead a summary of this article on FAST.
Get bite-sized news via a new
cards interface. Give it a try.
Click here to return to FAST Tap here to return to FAST
FAST
April 30 : U.S. medical device maker Stryker on Thursday maintained its full-year profit outlook but missed Wall Street estimates for first-quarter profit and revenue, weighed down by softer demand for implants and devices used in complex procedures ranging from spinal to orthopedic surgeries.
The company, which makes joint replacements and medical implants to repair broken bones, reiterated its expectations for adjusted annual profit in the range of $14.90 to $15.10 per share.
Shares of the company were down 1.8 per cent in extended trading.
An Iranian-linked hacking group known as Handala in March claimed responsibility for a destructive cyberattack on Stryker, which caused disruptions to the medical device maker's operations, limiting access to the company's systems and reportedly delayed some surgeries.
CNA Games
Guess Word
Crack the word, one row at a time
Buzzword
Create words using the given letters
Mini Sudoku
Tiny puzzle, mighty brain teaser
Mini Crossword
Small grid, big challenge
Word Search
Spot as many words as you can
Show More
Show Less
Company staff and contractors had claimed on social media that the logo of the hacking group appeared on their login pages, but Reuters was not able to verify the posts.
Stryker primarily competes with Zimmer Biomet and Johnson & Johnson in the orthopedics market, where all three compete for market share across segments such as hip and knee replacements, trauma, and sports medicine.
Sales at Stryker's biggest segment, medical surgery and neurotechnology, rose 5 per cent to $3.21 billion in the quarter, but missed analysts' estimates of $3.83 billion.
The orthopedics segment saw a 6.3 per cent increase in sales to $2.81 billion, which beat analysts' expectations of $2.51 billion.
The Michigan-based company reported total revenue of $6.02 billion for the quarter ended March 31, below analysts' expectations of $6.35 billion, according to data compiled by LSEG.
Stryker earned $2.60 per share for the quarter on an adjusted basis, falling short of estimates of $2.98 apiece.
Newsletter
Week in Review
Subscribe to our Chief Editor’s Week in Review
Our chief editor shares analysis and picks of the week's biggest news every Saturday.
Sign up for our newsletters
Get our pick of top stories and thought-provoking articles in your inbox
Get the CNA app
Stay updated with notifications for breaking news and our best stories
Get WhatsApp alerts
Join our channel for the top reads for the day on your preferred chat app